Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients
Author:
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2009.01178.x/fullpdf
Reference19 articles.
1. Lamivudine as initial treatment for chronic hepatitis B in the United States;Dienstag;N Engl J Med,1999
2. Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection;Yao;J Hepatol,2000
3. Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders;Schiff;J Hepatol,2003
4. Durability of serologic response after lamivudine treatment of chronic hepatitis B;Dienstag;Hepatology,2003
5. Durability of HBeAg responses tolamivudine and interferon in the early post-treatment period in adults with chronic hepatitis B;Schiff;Hepatology,2000
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Higher HBeAg‐reversion virological relapse and lower sustained remission after treatment cessation in tenofovir‐treated HBeAg‐positive patients;Journal of Medical Virology;2023-11
2. Biomarkers for predicting nucleos(t)ide analogs discontinuation and hepatitis B virus recurrence after drug withdrawal in chronic hepatitis B patients;Hepatology Research;2022-02-21
3. Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen–Positive Patients;The Journal of Infectious Diseases;2021-12-11
4. Challenges in the discontinuation of chronic hepatitis B antiviral agents;World Journal of Hepatology;2021-09-27
5. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients;Hepatology International;2021-07-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3